Protein synthesis in guinea-pig liver. Incorporation of radioactive amino acids into proteins of the microsome fraction in vivo
Year: 1957
Type: article
Abstract: ANNELID PHOSPHOKINASES 307Hobson & Rees, 1955) and served to identify them by synthetic as opposed to degradative means.Throughout the species investigated the phospho- kinases predicted by the previous results were all proved to be present and capable ofphosphorylating the expected base.As was reported for some of the echinoderms (Needham & Baldwin, 1937), several annelids, e.g.Glycera gigantea, Nerei8 diversicolor and Myxicola infundibulum, contain a mixture of phosphagens and show that the enzyme systems for the synthesis and utilization of phosphagens in living muscle are completely duplicated.The experimental results again emphasize that creatine phosphate, acting as a phosphagen, is not confined to the echinoderms, protochordates and vertebrates, but is also present, often in considerable quantities, in the annelids.At the present time the distribution of creatine phosphate appears quite arbitrary.This fact lessens the value of the identi- fication of the phosphagens in evolutionary studies in the animal kingdom.SUMMARY 1.A method of extraction of guanidine phos- phokinases from annelid muscle is described.2. Transphosphorylation has been demonstrated and the synthesized guanidine phosphates have been identified.3. It is concluded that taurocyamine and glyco- cyamine phosphate as well as creatine phosphate can act as phosphagens in certain of the annelids.We would like to express our appreciation to the staff of the Marine Biological Laboratory, Plymouth, who provided much living material, and to the administrators of the Field Fund of University College, London, for a grant to cover part of this work.Also our thanks are due to Professor E.
Source: Biochemical Journal
DOI: 10.1042/bj0650307
Authors: J. L. Simkin, T. S. Work
Institution: National Institute for Medical Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funder: Eli Lilly and Company
OpenAlex ID: W70418530
